Last reviewed · How we verify
NCT05266534: myomectomy
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
NA trial testing Terlipressin in Myoma in 162 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | Wael Elbanna Clinic |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 162 |
| Start date | 30 December 2021 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Terlipressin — full drug profile →
- Carbetocin (CARBETOCIN) — full drug profile →
- Saline
Conditions studied
- Myoma — all drugs for Myoma →
Sponsor
Wael Elbanna Clinic
Who can join
Adults 16 to 40, female only, with Myoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05266534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Terlipressin
Trials testing the same drug.
- NCT07304466 — Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation · NA · not yet recruiting
- NCT06556472 — Safety and Efficacy of Continuous Infusion of Terlipressin With Norepinephrine Versus Norepinephrine Alone in Improving · NA · not yet recruiting
- NCT03130127 — Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis · NA · unknown
- NCT06108362 — Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients · Phase 4 · unknown
- NCT05315557 — Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic · NA · unknown
Other recruiting trials for Myoma
Currently open trials in the same condition.
- NCT05170230 — The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic · NA · recruiting
Other Wael Elbanna Clinic trials
Trials by the same sponsor.
- NCT05170230 — The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic · NA · recruiting
- NCT05154279 — The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and · NA · unknown
- NCT05242783 — The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myome · NA · completed
- NCT05050747 — Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle · completed
- NCT05014867 — Comparative Study to Assess the Ongoing Pregnancy Rate for Poor Responders Women Undergoing Different Embryo Transfer Pr · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05266534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wael Elbanna Clinic
- Last refreshed: 4 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05266534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing